Home Regulatory Updates Page 9

Regulatory Updates

Regulatory Updates

Mobocertinib Granted Conditional Marketing Authorization in Great Britain

Editorial Team - March 19, 2022

Olaparib as adjuvant Treatment in Germline BRCA-mutated HER2-negative High-risk Early Breast Cancer

European Medicines Agency Recommends Approval of Enfortumab Vedotin Monotherapy in Bladder Cancer

Low magnification micrograph of mantle cell lymphoma of the terminal ileum. Endoscopic biopsy. H&E stain. Photo Courtesy: 2020. Nephron. This file is licensed under the Creative Commons Attribution-Share Alike 3.0 Unported license.

U.S. FDA approves Phase 3 Study Design for Zilovertamab in the Treatment of Mantle Cell Lymphoma

Tisotumab Vedotin Approved for the Treatment of Recurrent or Metastatic Cervical Cancer

New Data Supports Use of Real-World Evidence to Assess Long-term Impact...

Peter Hofland, Ph.D - July 10, 2018

Why Do We Need a Right-to-Try Bill in America?

Jane Orient - June 12, 2018

U.S. FDA Grants Accelerated Approval for Neoadjuvant use of Pertuzumab in...

Editorial Team - October 1, 2013

Accelerated Approval of Pertuzumab for Neoadjuvant Treatment in High-risk, HER2-Positive Early...

Editorial Team - September 13, 2013

Timesaving, Subcutaneous Formulation of Trastuzumab for the Treatment of HER2-positive Breast...

Editorial Team - September 3, 2013

U.S. FDA Approves Lenalidomide for the Treatment of Patients with Mantle...

Editorial Team - June 7, 2013

Erlotinib is the First Personalized Medicine Approved for the Initial Treatment...

Editorial Team - May 15, 2013

Multinational Harmonization and Collaboration Needed – Regulators and Hospital Urged to...

Editorial Team - January 28, 2013

Deferasirox Approved by European Commission for Iron Overload in Patients with...

Editorial Team - December 22, 2012

European Medicines Agency Offers Positive Opinion Bevacizumab Based Treatment Beyond First...

Shaun Mehr, Associate Publisher - November 16, 2012

1...8910 Page 9 of 10

LATEST NEWS

Soft-Tissue Sarcomas Changes the Biology of Immune Cells Surrounding Tumors to Promote Tumor Growth

Editorial Team - June 22, 2022

Activating the Immune Response Enables Liver Cancer Patient’s Immune System to Kill Cancerous Cells

Editorial Team - June 21, 2022

Statue of a Woman with Incurable Breast Cancer Unveiled in Front of the Norwegian...

Editorial Team - June 20, 2022

Preventive Care May Be Free, but Follow-Up Diagnostic Tests Can Bring Big Bills

Michelle Andrews - June 14, 2022

Pioneering Novel Targeted Treatments in Lung Cancer

Editorial Team - June 10, 2022

Press Releases | Cancer

HALO Diagnostics, IncellDx Partner to Advance Novel Testing, Improve... June 29, 2022
The precision diagnostics leader and molecular diagnostics company are joining forces to develop new, innovative testing for urogenital cancers that will improve the standard of care.(PRWeb June 29, 2022)Read the full story at https://www.prweb.com/releases/2022/6/prweb18764263.htm
P-Cure to support Hadassah Medical Organization in being the first to... June 28, 2022
P-Cure Ltd., the provider of the most compact 360° gantry-less adaptive proton therapy system that can be installed in a linac vault, announced today a collaboration with Hadassah Medical...(PRWeb June 28, 2022)Read the full story at https://www.prweb.com/releases/2022/6/prweb18759722.htm
Liquid Biopsy Workflow Optimization for Improved Assay Sensitivity and... June 27, 2022
In this free webinar, learn about optimizing liquid biopsy workflow for better assay sensitivity with multianalyte applications. The featured speaker will discuss the multianalyte use of the PAXgene...(PRWeb June 27, 2022)Read the full story at https://www.prweb.com/releases/liquid_biopsy_workflow_optimization_for_improved_assay_sensitivity_and_multianalyte_applications_of_cell_free_rna_dna_and_ctcs_upcoming_webinar_hosted_by_xtalks/prweb18758694.htm